HIV vaccine trial shows promise in early safety testing
NCT ID NCT05781542
First seen Nov 14, 2025 · Last updated May 15, 2026 · Updated 27 times
Summary
This early-stage study tested a new DNA-based HIV vaccine in 46 healthy adults without HIV. The vaccine was designed to train the immune system to recognize and fight HIV. Researchers checked for side effects and measured immune responses. The goal was to see if the vaccine is safe and whether it triggers the desired immune reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alabama CRS (Site ID: 31788)
Birmingham, Alabama, 35294, United States
-
Bridge HIV CRS
San Francisco, California, 94102, United States
-
Brigham and Women's Hospital Vaccine CRS [30007]
Boston, Massachusetts, 02115, United States
-
CAPRISA eThekwini CRS
Durban, KwaZulu-Natal, 4013, South Africa
-
Durban Adult HIV CRS
Durban, KwaZulu-Natal, South Africa
-
Groote Schuur HIV CRS (Site ID: 31708)
Cape Town, Western Cape, 7925, South Africa
-
San Francisco Vaccine and Prevention CRS
San Francisco, California, 94102, United States
-
Soweto HVTN CRS
Johannesburg, Gauteng, South Africa
Conditions
Explore the condition pages connected to this study.